Clovis Oncology Inc, a cancer-focused drugmaker, is considering selling itself, three people familiar with the deal told Reuters this week. Clovis has tapped Credit Suisse AG and J.P. Morgan to help find a buyer, according to one of the sources, who wished to remain anonymous because the source was not permitted to speak to the media. Bloomberg first reported news of the possible deal earlier on Tuesday, after which shares of Clovis, which has a market value of about $2 billion, jumped 21 percent.
Help employers find you! Check out all the jobs and post your resume.
